Banner with Title

Performance evaluation report (PER) IVDR Overview

Performance Evaluation of In Vitro Diagnostic Medical Devices is a must for IVD manufacturers entering the European market. The new European IVD Regulation (EU IVDR) 2017/746, specifically guides manufacturers to conduct a performance evaluation of IVDs and submit the Performance evaluation report (PER) IVDR.

Book a meeting with our PER experts

The PER under EU IVDR stands as a key aspect of the overall technical documentation. The purpose of the performance evaluation is to produce clinical evidence that supports the manufacturer’s intended use. As per Article 56 (paragraph 3) of the IVDR, a performance evaluation plan IVDR must demonstrate the following:

  • Scientific Validity
  • Analytical Performance
  • Clinical performance

Within the Performance Evaluation Report (PER), the manufacturer must demonstrate sufficient clinical evidence that supports the intended use of the device in medical practice, and this needs to be updated throughout the life cycle of the device to support the clinical evaluation of IVDs.

For successful IVDR compliance, manufacturers of in vitro diagnostic medical devices are required to be vigilant all through the performance evaluation process, which spans planning, collecting, and assessing the clinical evidence data and preparing and submitting the Performance Evaluation Report (PER), as part of the IVDR technical documentation.

To ensure that manufacturers of IVDs align with IVDR technical documentation requirements, Freyr performs a systematic review of the scientific literature and develops a performance evaluation plan along with a compliant Performance Evaluation Report (PER).

Get expert advice on your PER submission

Freyr Expertise and Advantages

Freyr Expertise

  • Transition plan for IVDR compliance.
  • Scientific validity reports based on literature and/or in-house data.
  • Clinical performance reports based on literature and/or in-house data.
  • Clinical Evidence or Performance Evaluation Reports as per IVDR.
  • Performance Evaluation Plan.
  • Post Market Performance Follow Up (PMPF) protocols and reports.
  • Post Market Surveillance (PMSR) protocols and reports.
  • Writing/Revising other documents, such as package insert/IFU, Quick Reference Instructions (QRI), operation/user manual, etc.

Freyr Advantages

  • Assured IVDR compliance, IVD registration, and CE marking
  • Proven expertise for IVDR technical documentation
  • Strong Regulatory understanding and expertise in EU IVDR key impact areas
  • Strong project management driven delivery model to ensure schedule adherence
  • Inhouse NB Experts (review of the report by NB interactive reviewers)
  • Focused teams with cross expertise on specific impact areas and device categories
  • Cross-functional inputs from Medical Device experts to comply with requirements
  • Full scope of service across compliance, review, and planning
  • Strong expertise in maintaining consistency in deliverables (time and quality) 

For end-to-end regulatory partnership on PER submissions, reach out to Freyr

Request for PER application submission